Medical Device Post-Market Surveillance Activities in GB

The UK authorities have published guidance concerning the implementation of post-marketing surveillance obligations in relation to medical devices in Great Britain. The regulatory obligations will begin to apply from 16 June 2025. The new guidance applies to four main areas: guidance on implementation of the Regulations; supplementary guidance concerning manufacturers’ vigilance system; periodic safety update reports; and device-specific vigilance.

Previous
Previous

Commission Taking ‘Due Account’ Of Scathing Report On EU Clinical Trial Bottlenecks

Next
Next

New Manufacturer’s Incident Report PMSV reporting forms - European Commission (Copy)